Stereotaxis Inc. Insider Trading

STXS

⊜ Compare

Last 12 months

Insiders bought 67K on the open market and sold nothing.

Net open-market

+67K

1 buy · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Nov 2025

Nov 17, 2025

Get an email when STXS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Nov 14, 2025 – Nov 17, 2025	Paul J Isaac Director	Bought 2 parts	30,000	$2.22 average	67K	1.1%	Form 4
Mar 10, 2025	Paul J Isaac Director	Bought	38,000	$1.81	69K	1.3%	Form 4
Mar 6, 2025 – Mar 7, 2025	Paul J Isaac Director	Bought 2 parts	24,788	$1.81 average	45K	0.9%	Form 4

Nov 14, 2025 – Nov 17, 2025
Paul J Isaac
Director · bought 30,000 at avg $2.22
67K
1.1% of stake
Mar 10, 2025
Paul J Isaac
Director · bought 38,000 at $1.81
69K
1.3% of stake
Mar 6, 2025 – Mar 7, 2025
Paul J Isaac
Director · bought 24,788 at avg $1.81
45K
0.9% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch STXS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Electromedical & Electrotherapeutic Apparatus · Pick stocks to compare with STXS

CompareIntrinsic value

POCIPrecision Optics Corporation, Inc.

$4.84+3.42%25

QTIQT Imaging Holdings, Inc.

$2.19+1.39%0

ECORElectroCore, Inc.

$8.40+16.18%40

HYPRHyperfine Inc.

$0.75+8.38%40

CVCapsoVision, Inc.

$6.85+2.24%21

ESMCEscalon Medical Corp

$0.19+4.00%20

NUWENuwellis Inc.

$5.27-10.83%35

IRIXIridex Corporation

$0.72+2.86%25

Held by ETFs

STXS is in 3 US ETFs. The largest of them, with STXS's weight in each:

Spot a number that looks wrong? Check it in STXS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing STXS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.